ANGO Financial Facts

Diluted weighted average shares outstanding: 36.7M
Operating income: 3.57M
See Full Income Statement

Inventories: 58.27M
Total current liabilities: 65.43M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 4/7/17 *Est. EPS Growth Rate +164.3% *Last Qtr.
Average EPS % Beat Rate +39.3% Revenue Growth Rate -0.2% *Last Qtr.
Average % Move 1-Wk after EPS +14.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/23/14 Q414 $0.18$0.12 +$0.06$94.1M$93.65M Details
7/16/15 Q415 $0.14$0.14 $0.00$90.9M$91.67M = Details
1/6/17 Q217 $0.37$0.16 +$0.21$89M$91.09M = Details
1/8/15 Q215 $0.17$0.15 +$0.02$92.1M$90.9M Details
4/9/15 Q315 $0.12$0.16 -$0.04$86.6M$89.8M Details
1/7/16 Q216 $0.14$0.14 $0.00$89.2M$88.67M = Details
7/13/16 Q416 $0.19$0.16 +$0.03$93.4M$88.41M = Details
1/9/14 Q214 $0.14$0.07 +$0.07$88.6M$87.54M N/A Details